Biltmore Family Office, LLC Aditxt, Inc. Transaction History

Biltmore Family Office, LLC

  • $566 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.34 - $0.58 $10,200 - $17,400
-30,000 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$0.54 - $2.51 $16,200 - $75,300
30,000 New
30,000 $16,000

About Aditxt, Inc.

ADTX Quotes by TradingView
  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $1.41M
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Biltmore Family Office, LLC Portfolio

Follow Biltmore Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email